From newborn screening to AI-enabled drug discovery and development, Revvity is at the forefront of scientific innovation aimed at improving human health. Our President & CEO Prahlad Singh spoke with J.D. Durkin of “Taking Stock” last Friday while at the NYSE for our 2026 Investor Day. Watch the full interview here to learn more about our latest work and where we’re headed: ms.spr.ly/6015xD93B
164
Our November image of the month is showing a cleared mosquito (Aedes aegypti formosus) with blue and green colors coming from autofluorescence. Imaged on the Opera Phenix™ Plus high-content screening system. ms.spr.ly/6016alSc8
Do you have any beautiful images from our HCS instruments? Please share – we’d love to see them!
2
296
AI predicts. The lab tests. Biology teaches.
See how Lab-in-the-Loop connects AI and experimental validation to keep discovery moving. ms.spr.ly/6019a0yvh
#ChallengeAccepted #AI
215
Looking for fresh perspectives on science and innovation?
Explore the Revvity blog for insights, industry trends, and expert perspectives on the latest advancements shaping life sciences and diagnostics.
Discover more: ms.spr.ly/6015aLma9
#Revvity #LifeSciences #Innovation
191
"Scientific innovation is increasingly dependent on the ability to coordinate work across people, systems and stages of development." - Kevin J. Willoe
Revvity Signals is taking another step forward with the introduction of the Signals LabGistics™ solution, an AI-first solution designed to streamline workflows, improve visibility, and connect processes from discovery through manufacturing.
Learn more via Technology Networks: ms.spr.ly/6010aLmQ0
261
Curious what life as a Field Service Engineer at Revvity really looks like?
Join us Wednesday, Oct 14 | 1:00 PM CET for a free 30-min live webinar. Straight talk from our Field Service Manager on travel, tech, training & career growth across Europe. Register now: ms.spr.ly/6014aUIXE
Secure your spot today!
192
Curious what life as a Field Service Engineer at Revvity really looks like? Join us Wednesday, Oct 14 | 1:00 PM CET for a free 30-min live webinar. Straight talk from our Field Service Manager on travel, tech, training & career growth across Europe. Register now: ms.spr.ly/6019aUSO1
Secure your spot today!
201
Our October image of the month shows primary dermal fibroblasts isolated from a patient with systemic sclerosis. Imaged on the Opera Phenix™ high-content screening system. ms.spr.ly/6017alo1Z
Color key: α-smooth muscle actin in magenta, Collagen I in yellow, Fibronectin in cyan, and Nuclei in blue.
Do you have any beautiful images from our HCS instruments? Send them over – we’d love to see them!
How do insurance coverage and reimbursement policies impact the diagnostic journey? Dr. Madhuri Hegde joins @DNATodayPodcast to discuss real-world barriers affecting access to genomic testing and patient care. Listen to the conversation: ms.spr.ly/6015aP2oF
#Genomics #GeneticTesting #RareDisease #PrecisionMedicine
Curious where your Revvity journey could begin? Find out by joining the people who make Revvity an extraordinary place to work! Search jobs now: ms.spr.ly/6011aOj23
Innovation thrives when people bring their whole selves to work. At Revvity, diverse perspectives help create meaningful change.
#PowerfulPurpose #ConnectedColleagues #InnovativeCulture
283
Curious where your Revvity journey could begin? Find out by joining the people who make Revvity an extraordinary place to work! Search jobs now: ms.spr.ly/6019azOTV
Many directions. One community.
Every career journey is different.
What connects us is a team that supports one another along the way.
#PowerfulPurpose #ConnectedColleagues #InnovativeCulture
311
Revvity retweeted
🧬 Getting a genetic test ordered is only part of the process. Getting it covered can be another challenge entirely.
Dr. Madhuri Hegde of @Revvity shares her perspective on navigating the insurance landscape.
🎧 Episode 405 of DNA Today podcast
dnapodcast.com/episodes/2026…
Be amazed by our August image of the month showing an infection structure of the plant-pathogenic fungus, Botrytis cinerea, observed using an Opera Phenix™ Plus high-content screening system. ms.spr.ly/6014vdagG
Color key: nuclei in far-red, lipid droplets in orange, chitin in the fungal cell wall in bright blue, calcofluor in white, hyphal tips in green, autofluorescence from the organism in pink.
Do you have any beautiful images from our HCS instruments? Send them – we’d love to see them!
338
The science exists. Access doesn't always. See how newborn screening is expanding across sub-Saharan Africa. ms.spr.ly/6017aEsAR
#ChallengeAccepted
363
Everyone is here at #ADLM2026 to help deliver the best in autoimmune, infectious, and endocrine testing. Booth #1411 come check us out and say hello!
#ADLM2026 #EUROIMMUN
282
Revvity’s Vice President of Platforms, Kevin Quick, speaks about the trends of technologies that support the cancer research community, and how they have been moving developers from discovery data to reliable therapeutic predictions. @DrugDiscovNews
ms.spr.ly/6014vfOZg
207
Behind every new reagent launch are multiple teams working to support your science. Meet a few of the people who make sure the latest innovations reach your lab.
Explore what's new and save 25% on select reagents with code NPI26Q3: ms.spr.ly/6017vFOr5
1
189
Have a look at our July image of the month showing vascular multiplexing by immunofluorescence on the tibia of a five-week-old mouse, acquired on the Operetta™ CLS high-content analysis system.
ms.spr.ly/6013vdabN
Color key: NG2 in red, endomucin in green, and alpha-SMA in orange
Do you have any beautiful images from our HCS instruments? Send them – we’d love to see them!
1
178
This summer, we're celebrating the adventures, passions, and places that make our people unique—wherever life takes them.
Where has Revvity traveled with you? Share your photos in the comments.
Ready to start your own journey? Explore opportunities at our locations around the world:
ms.spr.ly/6014vaCtC
144
AI is only as powerful as the data behind it. Through collaboration with Lilly, new models are learning across organizations, without sharing data.
Bridging the gap from data to discovery. Challenge accepted. ms.spr.ly/6012vQ3tM
#ChallengeAccepted #Organoids #DrugDiscovery
204
















